Breast cancer Programs in Pharmaceutical Benefits Scheme (PBS) 012-18051106
Expand allThis document outlines details of PBS-subsidised lapatinib, pertuzumab, trastuzumab, trastuzumab deruxtecan and trastuzumab emtansine for patients with breast cancer.
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings.
On this page:
Early HER2 positive breast cancer (HER2-positive EBC) quick reference
Metastatic (Stage IV) HER2 positive breast cancer (HER2-positive metBC) quick reference
Unresectable and/or metastatic HER2-low breast cancer (HER2-low BC) quick reference
Early HER2 positive breast cancer (HER2-positive EBC) quick reference
Table 1
|
Restrictions |
Authority level and section |
PA assessment |
Processing system |
Prescriber type |
Prescriber self-serve |
|
Initial PB289 form |
Written Electronic S100: trastuzumab emtansine |
No |
OPA |
Not specified |
Yes |
|
Initial |
Streamlined S100: trastuzumab i.v. (telephone for increased quantity and/or repeats for patients > 125 kg only) |
No |
N/A |
Not specified |
N/A |
|
Continuing |
Telephone Electronic S100: trastuzumab emtansine |
No |
OPA |
Not specified |
Yes |
|
Continuing |
Streamlined S85: trastuzumab s.c. S100: trastuzumab i.v. (telephone for increased quantity and/or repeats for patients > 125 kg only) |
No |
N/A |
Not specified |
N/A |
Metastatic (Stage IV) HER2 positive breast cancer (HER2-positive metBC) quick reference
Table 2
|
Restrictions |
Authority level and section |
PA assessment |
Processing system |
Prescriber type |
Prescriber self-serve |
|
Initial PB099 form |
Written Electronic S85: lapatinib |
No |
OPA |
Not specified |
Yes |
|
Initial |
Streamlined S85: trastuzumab s.c. S100: trastuzumab i.v. (telephone for increased quantity and/or repeats for patients > 125 kg only) |
No |
N/A |
Not specified |
N/A |
|
Initial and Continuing |
Telephone Electronic S100: pertuzumab i.v. trastuzumab deruxtecan trastuzumab emtansine |
No |
OPA |
Not specified |
Yes |
|
Continuing |
Streamlined S85: lapatinib trastuzumab s.c. S100: trastuzumab i.v.(telephone for increased quantity and/or repeats for patients > 125 kg only) |
No |
N/A |
Not specified |
N/A |